Rezolute RZLT
NASDAQ RZLT
$4.07 +0.05 (+1.24%)
At close: Nov 11, 2026 · 4:00 PM EST

Rezolute (RZLT) Net Margin (2019 - 2020)

Updated

Rezolute's Net Margin was -120666.67% in fiscal Q1 2021 (quarter ended Sep 30, 2020), down 49726.67 percentage points from the prior quarter.

Analysis

Rezolute (RZLT) Net Margin (2019 - 2020) Analysis & Trends

On a trailing twelve-month basis, Rezolute's Net Margin was -20514.13% through Sep 30, 2020; for FY2020 (ended Jun 30, 2020), it was -10815.43%, down 60651.49 percentage points from FY2019.

  • In earlier fiscal years, Net Margin was 49836.07% in FY2019.
  • The fiscal Q1 2021 figure marks the lowest quarterly Net Margin since fiscal Q3 2019.
  • Per Business Quant data, RZLT's Net Margin in the three fiscal quarters before Q1 2021 was -70940.00% (Q4 2020), -16800.00% (Q3 2020) and -12344.44% (Q2 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 26.44%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.83%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 24.24%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 28.01%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 20.69%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 37.28%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 29.27%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 19.55%
10 Rezolute 388.82 Mn -62.24 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -120,666.67%
Jun 30, 2020 -70,940.00%
Mar 31, 2020 -16,800.00%
Dec 31, 2019 -12,344.44%
Jun 30, 2019 117,754.02%
Mar 31, 2019 -183,715.04%
API Access

Rezolute Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=RZLT&period=max&api_key=YOUR_API_KEY